CRLX101 (formerly IT-101) A Novel Nanopharmaceutical of Camptothecin in Clinical Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-6646|7|1|8-14

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.7, Iss.1, 2011-03, pp. : 8-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

XMT-1001, A Novel Biodegradable Polyacetal Polymer Conjugate of Camptothecin in Clinical Development

By  

Current Bioactive Compounds, Vol. 7, Iss. 1, 2011-03 ,pp. : 15-20

Bentham Science Publishers

Access to resources Recommend Favorite

A Regulatory Perspective on Clinical Trials: FDA 101 for Clinicians

By  

Child and Adolescent Psychopharmacology News, Vol. 18, Iss. 3, 2013-06 ,pp. : 4-7

Guilford Publications Inc

Access to resources Recommend Favorite

Design, Synthesis and Development of Novel Camptothecin Drugs

By  

Current Pharmaceutical Design, Vol. 14, Iss. 11, 2008-04 ,pp. : 1078-1097

Bentham Science Publishers

Access to resources Recommend Favorite

TSG101: A Novel Anti-HIV-1 Drug Target

By  

Current Medicinal Chemistry, Vol. 17, Iss. 8, 2010-03 ,pp. : 750-758

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches Targeting KV10.1 Open a Novel Window for Cancer Diagnosis and Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 5, 2012-02 ,pp. : 675-682

Bentham Science Publishers

Access to resources Recommend Favorite